Viatris Inc. closed 39.78% short of its 52-week high of $13.55, which the company achieved on November 25th.
NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.
2d
Barchart on MSNHow Is Viatris’ Stock Performance Compared to Other Biotech Stocks?With a market cap of $14.8 billion, Viatris Inc. (VTRS) is a global pharmaceutical company formed in 2020 through the merger ...
VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock.
On March 7, Reuters cited a Goldman Sachs report highlighting that hedge funds specializing in stock picking ... on Viatris Inc. (NASDAQ:VTRS), though he revised his price target downward from ...
Today, VTRS has 4 main geographic divisions ... and if the stock goes well below my put strike price, I can still sell the stock at that put level, before that option expires.
The consensus price target of $11 implies 16.03% upside. Viatris Inc. (NASDAQ:VTRS) stock is down 23.86% year-to-date. Overall VRT ranks 12th on our list of the large-cap stocks that are plunging ...
Viatris Inc. closed 36.53% short of its 52-week high of $13.55, which the company reached on November 25th.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results